0000929638-24-003098.txt : 20240906 0000929638-24-003098.hdr.sgml : 20240906 20240906130321 ACCESSION NUMBER: 0000929638-24-003098 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240906 DATE AS OF CHANGE: 20240906 EFFECTIVENESS DATE: 20240906 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RenBio, Inc. CENTRAL INDEX KEY: 0001840723 ORGANIZATION NAME: IRS NUMBER: 465353064 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-523398 FILM NUMBER: 241283763 BUSINESS ADDRESS: STREET 1: 430 EAST 29TH STREET STREET 2: SUITE 600 CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: (646) 440-9411 MAIL ADDRESS: STREET 1: 430 EAST 29TH STREET STREET 2: SUITE 600 CITY: NEW YORK STATE: NY ZIP: 10016 D 1 primary_doc.xml X0708 D LIVE 0001840723 RenBio, Inc. 30-02 48th Avenue Long Island City NY NEW YORK 11101 (646) 440-9411 DELAWARE None None Corporation true 2020 Rachel A. Liberatore, Ph.D. c/o 30-02 48th Avenue Long Island City NY NEW YORK 11101 Director Executive Officer Donald Tang c/o 30-02 48th Avenue Long Island City NY NEW YORK 11101 Director Jaap Goudsmit, M.D., Ph.D. c/o 30-02 48th Avenue Long Island City NY NEW YORK 11101 Director Zhi Hong, Ph.D. c/o 30-02 48th Avenue Long Island City NY NEW YORK 11101 Director Walter Wang, Sr. c/o 30-02 48th Avenue Long Island City NY NEW YORK 11101 Director Annelyn O'Rourke c/o 30-02 48th Avenue Long Island City NY NEW YORK 11101 Executive Officer Biotechnology Decline to Disclose 06b false 2024-08-22 false true true true false 0 6000000 5250000 750000 false 7 0 0 0 true RenBio, Inc. /s/ Rachel A. Liberatore, Ph.D Rachel A. Liberatore, Ph.D. President and Chief Scientific Officer 2024-09-04